Expression of glucose transporters in cancers
- PMID: 23266512
- DOI: 10.1016/j.bbcan.2012.12.004
Expression of glucose transporters in cancers
Abstract
It has been known for 80 years that cancer cell growth in an energy-related process supported by an increased glucose metabolism. This phenomenon suggests a need for a corresponding increased uptake of glucose across the plasma membrane through an enhancement in the glucose transporter proteins, SGLT proteins as well as GLUT proteins. The results of many studies have demonstrated that the expression of glucose transporters, especially GLUT1, is increased in a variety of malignancies. GLUT1 overexpression has been found to be associated with tumor progression. It was found that GLUT1 overexpression is associated with poor overall survival in various malignant tumors.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.Chemotherapy. 2007;53(4):233-56. doi: 10.1159/000104457. Epub 2007 Jun 25. Chemotherapy. 2007. PMID: 17595539 Review.
-
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.Metabolism. 2016 Feb;65(2):124-39. doi: 10.1016/j.metabol.2015.10.007. Epub 2015 Nov 13. Metabolism. 2016. PMID: 26773935 Review.
-
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.Clin Nucl Med. 2012 Feb;37(2):121-7. doi: 10.1097/RLU.0b013e3182393599. Clin Nucl Med. 2012. PMID: 22228332
-
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.J Cell Physiol. 2005 Mar;202(3):654-62. doi: 10.1002/jcp.20166. J Cell Physiol. 2005. PMID: 15389572 Review.
-
Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response.Theranostics. 2020 Jul 25;10(21):9579-9590. doi: 10.7150/thno.48954. eCollection 2020. Theranostics. 2020. PMID: 32863946 Free PMC article.
Cited by
-
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.J Bioenerg Biomembr. 2016 Aug;48(4):349-62. doi: 10.1007/s10863-016-9670-z. Epub 2016 Jul 25. J Bioenerg Biomembr. 2016. PMID: 27457582 Review.
-
Deletion of Glutathione S-Transferase Omega 1 Activates Type I Interferon Genes and Downregulates Tissue Factor.Cancer Res. 2020 Sep 1;80(17):3692-3705. doi: 10.1158/0008-5472.CAN-20-0530. Epub 2020 Jun 22. Cancer Res. 2020. PMID: 32571799 Free PMC article.
-
Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo.J Am Chem Soc. 2016 Sep 28;138(38):12541-51. doi: 10.1021/jacs.6b06937. Epub 2016 Sep 16. J Am Chem Soc. 2016. PMID: 27570149 Free PMC article.
-
Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.Biomed Res Int. 2015;2015:390863. doi: 10.1155/2015/390863. Epub 2015 Apr 15. Biomed Res Int. 2015. PMID: 25961014 Free PMC article. Review.
-
Novel Photosensitizer β-Mannose-Conjugated Chlorin e6 as a Potent Anticancer Agent for Human Glioblastoma U251 Cells.Pharmaceuticals (Basel). 2020 Oct 16;13(10):316. doi: 10.3390/ph13100316. Pharmaceuticals (Basel). 2020. PMID: 33081106 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
